Suppr超能文献

服用坦索罗辛患者术中虹膜松弛综合征的临床特征、并发症及发生率

Clinical features, complications, and incidence of intraoperative floppy iris syndrome in patients taking tamsulosin.

作者信息

Takmaz T, Can I

机构信息

Ataturk Training and Research Hospital, 2nd Ophthalmology Department, Ankara, Turkey.

出版信息

Eur J Ophthalmol. 2007 Nov-Dec;17(6):909-13. doi: 10.1177/112067210701700607.

Abstract

PURPOSE

To evaluate the intraoperative findings, complication rates, effect of intracameral adrenaline, and incidence of intraoperative floppy iris syndrome (IFIS) in patients using tamsulosin.

METHODS

In this prospective nonrandomized observational study, 858 eyes of 774 patients who had phacoemulsification between August 2005 and November 2006 were evaluated. Duration and preoperatively discontinuing time of tamsulosin intake were questioned. Preoperative pupil size, intraoperative iris behavior, progressive miosis, adrenalin usage, and complications were recorded.

RESULTS

The incidence of IFIS was 1.6% and IFIS was seen in 14 of the 18 eyes of patients using tamsulosin (77.8%). One eye had floppy iris only, 2 eyes had floppy iris and intraoperative miosis, 3 eyes had floppy iris and iris prolapse, and 8 eyes had all three signs of IFIS. IFIS was seen in 7 of the 10 eyes where intracameral adrenaline was used, and in 7 of the 8 eyes without adrenaline (p=0.588). Intraoperative miosis was seen only in 3 of the 10 eyes with adrenaline and in 7 of the 8 eyes without adrenaline (p=0.025). Posterior capsule rupture occurred in 1 of the eyes with IFIS and in 5 eyes focal iris stromal atrophy caused by prolapse was seen.

CONCLUSIONS

IFIS occurred in 1.6% of cases having phacoemulsification. Intracameral adrenaline usage did not change the IFIS occurrence rate, but it seemed to be effective in preventing intraoperative miosis. There are still many questions about IFIS, and there is need for future studies strengthening the understanding of IFIS.

摘要

目的

评估使用坦索罗辛患者的术中发现、并发症发生率、前房内肾上腺素的作用以及术中虹膜松弛综合征(IFIS)的发生率。

方法

在这项前瞻性非随机观察性研究中,对2005年8月至2006年11月期间接受超声乳化手术的774例患者的858只眼进行了评估。询问了坦索罗辛的服用时长和术前停药时间。记录术前瞳孔大小、术中虹膜表现、渐进性瞳孔缩小、肾上腺素使用情况及并发症。

结果

IFIS的发生率为1.6%,在使用坦索罗辛患者的18只眼中有14只出现IFIS(77.8%)。1只眼仅有虹膜松弛,2只眼有虹膜松弛和术中瞳孔缩小,3只眼有虹膜松弛和虹膜脱垂,8只眼具备IFIS的所有三种体征。在使用前房内肾上腺素的10只眼中有7只出现IFIS,未使用肾上腺素的8只眼中有7只出现IFIS(p = 0.588)。术中瞳孔缩小仅在使用肾上腺素的10只眼中有3只出现,未使用肾上腺素的8只眼中有7只出现(p = 0.025)。1只出现IFIS的眼中发生了后囊破裂,5只眼中可见因脱垂导致的局限性虹膜基质萎缩。

结论

在接受超声乳化手术的病例中,IFIS的发生率为1.6%。前房内使用肾上腺素并未改变IFIS的发生率,但似乎对预防术中瞳孔缩小有效。关于IFIS仍有许多问题,未来需要加强对IFIS认识的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验